Home » Newsletters » BioWorld Science

BioWorld Science

May 3, 2022

View Archived Issues

OQL-051 shows prophylactic efficacy in models of chemotherapy-induced diarrhea

New EGFR inhibitors discovered at the Dana-Farber Cancer Institute

Storm Therapeutics identifies new METTL3 inhibitors

GlaxoSmithKline synthesizes new MRGPRX2 antagonists

Lilly patents dopamine D1 receptor positive allosteric modulators

Serine/threonine-protein kinase Pim-1 inhibitors identified at Japan Tobacco

Allogeneic colorectal cancer vaccine active against anti-PD-1-resistant colon cancer

S trimer-engaging multivalent protein neutralizes SARS-CoV-2 variants and protects mice

Identification of human MAb that broadly neutralizes sarbecoviruses unveils a crucial CDRH3 motif

Hemispherian closes seed funding to advance preclinical pipeline for cancer

Gilead and Dragonfly collaborate to advance NK cell engager-based immunotherapies

ProfoundBio antibody-drug conjugate PRO-1102 shows potency in vitro and in vivo

Ring Therapeutics describes in vitro system enabling human anellovirus production

Novel TRPC5 inhibitors show potential for the treatment of CKD

Tripartite interactions between nervous system, immune cells and plaques drive atherosclerosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....